CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- 4 Open-market buy Director bought 21,654 shares at an average $8.96 ($194,040)
- 4 Open-market buy Director bought 32,876 shares at an average $8.89 ($292,126)
- 4 Open-market buy Director bought 531,326 shares at an average $8.66 ($4,599,903)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,027,722 shares at an average $7.44 ($7,650,148)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 1,432,291 shares at $11.52 ($16,499,992)
- 4 Open-market sale SVP, Research and Development sold 3,095 shares at $9.01 ($27,879)
- 4 Open-market sale Chief Tech Operations Officer sold 7,002 shares at $9.01 ($63,073)
- 4 Open-market sale COO, CLO, Compliance Officer sold 8,790 shares at $9.01 ($79,179)
- 4 Open-market sale Chief Medical Officer sold 7,037 shares at $9.01 ($63,386)
- 4 Open-market sale Chief Executive Officer sold 27,116 shares at $9.01 ($244,253)
- 4 Grant or award President & Head of R&D acquired 77,500 shares (grant or award)
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 4 of 12 · 234 filings